APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis Hong YouXiong MaJidong Jia Guidelines Open access 04 February 2022 Pages: 1 - 23
Non-alcoholic fatty liver disease in cerebrovascular disease: a bystander or a real risk factor? Lung-Yi MakJames Fung Editorial 27 January 2022 Pages: 24 - 26
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review Huimin ZouYing GeHao Hu Review Article 31 January 2022 Pages: 27 - 37
Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection Zhongwei ZhangZhongyuan YangQin Ning Original Article 02 December 2021 Pages: 38 - 47
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study Lung-Yi MakJoseph HoangMindie H. Nguyen Original Article 25 November 2021 Pages: 48 - 58
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study) Jee-Fu HuangMing-Yen HsiehWan-Long Chuang Original Article 30 November 2021 Pages: 59 - 67
Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers Minami KikuchiMotoji SawabeHideki Aizaki Original Article 02 December 2021 Pages: 68 - 80
Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke Takahisa MoriKazuhiro YoshiokaYuhei Tanno Original Article Open access 15 September 2021 Pages: 81 - 88
Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria Ankur JindalSanchit SharmaShiv Kumar Sarin Original Article 24 January 2022 Pages: 89 - 98
Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer Tuo DengJialiang LiGang Chen Original Article 22 January 2022 Pages: 99 - 111
A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes Sizhe WanYiming LeiBin Wu Original Article 27 August 2021 Pages: 112 - 124
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies M. IllianoM. ColinardB. Fresneau Original Article 10 September 2021 Pages: 125 - 134
Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period Masaki KaiboriKazuko SakaiKazuto Nishio Original Article Open access 01 January 2022 Pages: 135 - 147
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial Wei-Ting ChenShi-Ming LinChau-Ting Yeh Original Article 04 January 2022 Pages: 148 - 158
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study Gamal ShihaNabiel N. H. MikhailMohammed Eslam Original Article 16 January 2022 Pages: 159 - 170
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure Kessarin ThanapiromTongluk TeerasarntipanThe APASL ACLF Working Party Original Article Open access 25 November 2021 Pages: 171 - 182
Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China Xue MeiHai LiZhiping Qian Original Article 17 January 2022 Pages: 183 - 194
Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis Sha ChenTingting LvJidong Jia Original Article 14 January 2022 Pages: 195 - 206
Iodized oil CT-guided radiofrequency ablation for hepatocellular carcinoma within Milan criteria Lei DuanBo-Han ZhangXiao-Hua Zheng Letter to the Editor 28 January 2022 Pages: 207 - 208
Response to “Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria” Chih-Horng WuJia-Horng Kao Letter to the Editor 28 January 2022 Pages: 209 - 210
